Nebraska Passes PANS/PANDAS Insurance Coverage Law

Jul 26

For families living with PANS and PANDAS, finding a doctor who understands the illness can be difficult enough. Then comes another fight: convincing an insurance company to cover the treatment that doctor recommends.

Nebraska families now have an important new protection.

Type: State insurance law
Bill: LB 762
Passed: April 10, 2026
Signed: April 14, 2026
Effective: January 1, 2027
Coverage: Certain individual and group health insurance policies and some self-funded employee benefit plans where federal law does not take precedence
Treatments named: Antibiotics, medications, behavioral therapies, plasma exchange and immunoglobulin therapy

Governor Jim Pillen signed LB 762 into law after it passed the Nebraska Legislature with strong bipartisan support. Beginning January 1, 2027, covered health plans in Nebraska will be required to provide coverage for physician-recommended treatment of pediatric acute-onset neuropsychiatric syndrome, known as PANS, and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, known as PANDAS.

The law specifically names antibiotics, medications and behavioral therapies used to manage neuropsychiatric symptoms, plasma exchange and immunoglobulin therapy. That last category includes treatments such as intravenous immunoglobulin, commonly known as IVIG, which can be financially out of reach when families are forced to pay on their own.

A Family-Led Fight

LB 762 was shaped not only by legislative work, but also by testimony from families and medical professionals who helped lawmakers understand the practical effects of PANS, PANDAS, and treatment denials.

Grace Troupe became one of the leading voices behind the effort after both of her daughters, Violet and Belle, were diagnosed. In February, the two elementary school-aged girls joined their mother at the Nebraska State Capitol to testify before lawmakers.

They helped put real children and real families behind an issue that can otherwise be reduced to medical terminology and insurance language. Their advocacy showed lawmakers what is at stake when a child needs treatment and an insurance denial stands in the way.

State Senator George Dungan introduced LB 762 and made it a priority bill during Nebraska’s short legislative session. The measure ultimately passed its final vote 45–4 before being signed by the governor.

What the Law Means for Families

The new law gives Nebraska families clearer grounds for seeking insurance coverage when a licensed physician recommends treatment for PANS or PANDAS.

It does not mean that every treatment will be automatically approved or that the law applies to every health plan. Some employer-sponsored plans are regulated primarily under federal law and may fall outside the reach of a state insurance requirement. Limited-benefit and specified-disease policies are also excluded.

Families will still need to understand their individual plan, meet applicable medical criteria and work through the authorization process. But the law creates something families did not have before: a clear requirement that covered plans recognize and provide benefits for medically recommended PANS and PANDAS treatment.

That is a meaningful step forward.

What Nebraska’s Law Adds to the National Picture

Nebraska’s law is part of a broader pattern of states formally recognizing the need for insurance coverage of PANS and PANDAS treatment.

LB 762 provides a recent example of how that coverage can be structured. The law identifies the types of health plans affected, requires coverage when treatment is recommended by a licensed physician, and specifically names antibiotics, medications, behavioral therapies, plasma exchange, and immunoglobulin therapy.

For policymakers, Nebraska offers another legislative model to review alongside laws enacted in other states. Its language, treatment categories, plan limitations, legislative history, and implementation timeline provide a practical point of comparison for states considering similar protections.

For families, the law offers greater clarity and a stronger basis for requesting coverage for medically recommended care. It also reflects a growing acknowledgment that PANS and PANDAS can create serious medical, psychiatric, educational, and financial consequences when appropriate treatment is delayed or denied.

Nebraska’s action adds to the national record showing that insurance coverage for PANS and PANDAS is not an isolated policy question. States across the country are evaluating how their health systems respond to these conditions and how families can access the care their physicians recommend.